Sleep for Health Study on the Effects of Cognitive Behavioral Therapy for Insomnia on Diabetes Risk
Part of paid clinical trials in Portland, Oregon.
- Sponsor
- Kaiser Permanente
- Study ID
- NCT06067139
- Status
- Recruiting
Conditions
- Diabetes Mellitus, Type 2
- Prediabetic State
- Sleep Initiation and Maintenance Disorders
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - 79 Years
- Healthy Volunteers
- Not accepted
Interventions
- SHUTi — OTHEREach core includes a variety of interactive features, such as animations, vignettes, "myth" and "reality" buttons that reveal common misperceptions and facts about sleep, "learn more" buttons that provide in-depth information about a topic, and quizzes. All cores follow a similar structure with objectives, main content, homework, and review. Participants are free to revisit cores as many times as they like.
- Patient Education — OTHERThe PE website will present content in a simple, static form, without interactive components; and all content on the website will be provided at once, rather than in modules that unlock over time. The PE website will also not provide personalized or individually tailored treatment recommendations.
Study Details
This study tests whether providing cognitive behavioral therapy for insomnia (CBT-I) to people with prediabetes results in a reduction in glucose levels compared to a patient education control program.
Key Dates
- Start date
- Aug 1, 2023
- Status verified
- Dec 2025
- Primary completion
- Mar 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 300 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Digital cognitive behavioral therapy (dCBT-I)CBT-I is designed to change sleep habits and scheduling factors that affect sleep, and to address misconceptions about sleep and insomnia that perpetuate sleep difficulties. The investigators will employ SHUTi, which is an extensively studied dCBT-I program. SHUTi is intended to improve insomnia symptoms by providing neurobehavioral intervention (cognitive behavioral therapy for insomnia - CBT-I) in adults with chronic insomnia. It is a six-core internet-delivered CBT-I web-based app that is run through a browser. It is accessible via iPhone/iPad, Android phone/tablet, computer or laptop (any device with a browser). SHUTi follows evidence-based CBT-I principles.
- Active Comparator: Patient Education (PE)Participants will be given access to a patient education website. It will provide nontailored material about insomnia symptoms; the impact, prevalence, and causes of insomnia; and basic lifestyle, environmental, and behavioral strategies to improve sleep.
Primary Outcome Measure
2-hour post-load glucose (2hPG) (mg/dL) [ Time Frame: V1 (baseline), V2 (11 weeks after randomization), V3 (33 weeks from randomization) ]
Central Contacts
- Stefan Massimino, MS971-232-9343
- Chris Catlin971-369-0655
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Kaiser Permanente Center for Health Research | Portland | Oregon | 97227 | Erin LeBlanc, MD (PRINCIPAL_INVESTIGATOR) Greg Clarke, PhD (SUB_INVESTIGATOR) |
Find similar trials in Portland, OR
By condition
By specialty
By research site
Related Studies
- Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesPHASE4 · Recruiting · VA Office of Research and Development · Phoenix, Arizona
- An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)Enrolling By Invitation · Novo Nordisk A/S · Morgantown, West Virginia
- Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)Recruiting · The University of Texas Health Science Center at San Antonio · San Antonio, Texas
- Wake Forest Alzheimer's Disease Clinical CoreRecruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina